Skip to main content
Clinical Trials/NL-OMON52802
NL-OMON52802
Recruiting
Phase 3

IMPROVE: Improving anxiety treatment by Modulating emotional memories PRiOr to in Vivo Exposure: A randomized controlled trial. - IMPROVE - Modulating emotional memories: a RCT

niversiteit Utrecht0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
panic disorder (involuntary reoccurring panic attacks)
Sponsor
niversiteit Utrecht
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients of \>18 years of age
  • \- Sufficient mastery of the Dutch language to complete questionnaires
  • \- Ability to understand questionnaires and written informed consent
  • \- Meeting DSM\-5 criteria for primary panic disorder (with or without
  • agoraphobia) (assessed with MINI\-S\-DSM\-5\)
  • \- Stable medication for at least six weeks and willingness by the patient and
  • physician to keep the medication stable during the study period (until FU1\).
  • The use of sedating medication (e.g. benzodiazepines) is no contraindication,
  • however participants are strongly advised not to use sedating medication prior
  • to\- or after treatment sessions and subsequent days. Use of sedating medication

Exclusion Criteria

  • \- Neurological disorder
  • \- Acute or recent history of suicide attempts according to the M.I.N.I. section
  • \- Self\-reported visual or auditory impairments that could hinder treatment
  • \- Self\-reported epilepsy, pregnancy, or heart disease (these are common
  • exclusion criteria for using a fear conditioning task, see 8\.3\.3\)
  • \- Not willing or able to fill in (online) questionnaires.

Outcomes

Primary Outcomes

Not specified

Similar Trials